Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
2026 Q1 -tulosraportti
2 päivää sitten

Tarjoustasot

DenmarkNasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
57--
2 865--
360--
5 425--
5 817--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q2 -tulosraportti
20.8.
Menneet tapahtumat
2026 Q1 -tulosraportti
21.5.
2025 Q4 -tulosraportti
26.3.
2025 Q3 -tulosraportti
19.11.2025
2025 Q2 -tulosraportti
15.8.2025
2025 Q1 -tulosraportti
8.5.2025

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 11 t sitten
    ·
    11 t sitten
    ·
    Just want to note that BP's increases historically have been driven by hysteria! These days/weeks/month(s) something "calmly" increasing is happening. And that, I think, is a sign of health. It doesn't jump by, for example, 75 øre. It seems to ground itself a bit à la two steps forward and one back. It looks calmer. It looks promising. Regards. Bagerbrød
    8 t sitten
    ·
    8 t sitten
    ·
    What could I possibly mean by "gently rising"?
    5 t sitten
    ·
    5 t sitten
    ·
    Thanks and likewise 😊🐾
  • 16 t sitten
    ·
    16 t sitten
    ·
    The price finally seems to be turning around, as there are green %-s for the last 6 months, but there is still room for improvement. 2.0 must be the next target this year.
    16 t sitten
    ·
    16 t sitten
    ·
    It depends on when KDIGO comes out with a 1st degree recommendation for the NGAL test. Those of us who have kept the stock in our portfolio, and have bought at the bottom, we can just lean back and watch all those who only buy when the announcement is made public. Bioporto has announced that they have already acquired 4 new hospitals in Q1. The reason why these hospitals have already integrated the NGAL test in Q1 and not in Q4, (see CBs explanation in Webcast Q 4 2025) is due to KDIGO's draft and the various announcements before the hearing concluded. We know that FDA will approve the adult test, it's just a question of when.
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    KDIGO guidelines likely the next catalyst - Q1 review https://access.dnbcarnegie.com/publication/ef21af0f-6d31-42be-0550-08deb7025c09
    5 t sitten
    ·
    5 t sitten
    ·
    Progression has formed a private club here on Nordnet, and there are 5 members. These are members who have all lost money on Bioporto, and they have made a pact to go together and commit a shit storm on Bioporto, on which they lost money, as revenge. According to themselves. You can figure out that progression is one member, and the others are those who follow along when a shit storm is to be carried out, either by liking each other's writings and/or they back each other up by contributing posts in the same style. As well as the posts I make, or others for that matter, if they are positive, they start coordinating their attack, as described above. They have not succeeded in making Bioporto go bankrupt, naturally, but they have succeeded in making so much noise that people have dumped their shares. But every time I and others come with negative news, there is silence from their side. I have long known that these attacks are coordinated, which I have claimed several times here on Nordnet social. Therefore, I have also actively looked for the smoking gun, and now I have found it and am sharing it here. Link to their closed club. https://www.nordnet.dk/forum/grupper/dk-progressionsklubben
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Why has Bioporto perhaps chosen to deliver a "decimated" quarterly report, where many of the usual details are omitted? And why hasn't 3D commented yet? Has 3D perhaps not noticed it?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    @Progression: Well, just that revenue increases while the loss decreases, and that is a good start to the year.
    1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    Revenue lands 6 % below the average quarterly sales in 2025. Has inflation been 4-5 % since 2025? Have sales on average fallen by 10 %? Is it the RSU sales that "drives" the business and not sales used in the healthcare sector? Is everything as it should be? The loss has become smaller vs Q1 25. Is there an explanation for the saving, has one sold fewer products at a higher price?
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Watch or rewatch Webcast Q 1 https://www.youtube.com/watch?v=FRc-y2wEHOM
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    It was a pleasure to hear the explanation that CB provided about KDIGO, because the analyses that I have arrived at, about KDIGO, and what it means for Bioporto, lean closely on what CB stated. The next thing I am excited about is whether I am also right that there will be a 1st degree recommendation for the critical areas, and a 2nd degree recommendation for other areas. (It is not unthinkable that there will be more recommendations than the two, so that it becomes as detailed as possible)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2026 Q1 -tulosraportti
2 päivää sitten

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 11 t sitten
    ·
    11 t sitten
    ·
    Just want to note that BP's increases historically have been driven by hysteria! These days/weeks/month(s) something "calmly" increasing is happening. And that, I think, is a sign of health. It doesn't jump by, for example, 75 øre. It seems to ground itself a bit à la two steps forward and one back. It looks calmer. It looks promising. Regards. Bagerbrød
    8 t sitten
    ·
    8 t sitten
    ·
    What could I possibly mean by "gently rising"?
    5 t sitten
    ·
    5 t sitten
    ·
    Thanks and likewise 😊🐾
  • 16 t sitten
    ·
    16 t sitten
    ·
    The price finally seems to be turning around, as there are green %-s for the last 6 months, but there is still room for improvement. 2.0 must be the next target this year.
    16 t sitten
    ·
    16 t sitten
    ·
    It depends on when KDIGO comes out with a 1st degree recommendation for the NGAL test. Those of us who have kept the stock in our portfolio, and have bought at the bottom, we can just lean back and watch all those who only buy when the announcement is made public. Bioporto has announced that they have already acquired 4 new hospitals in Q1. The reason why these hospitals have already integrated the NGAL test in Q1 and not in Q4, (see CBs explanation in Webcast Q 4 2025) is due to KDIGO's draft and the various announcements before the hearing concluded. We know that FDA will approve the adult test, it's just a question of when.
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    KDIGO guidelines likely the next catalyst - Q1 review https://access.dnbcarnegie.com/publication/ef21af0f-6d31-42be-0550-08deb7025c09
    5 t sitten
    ·
    5 t sitten
    ·
    Progression has formed a private club here on Nordnet, and there are 5 members. These are members who have all lost money on Bioporto, and they have made a pact to go together and commit a shit storm on Bioporto, on which they lost money, as revenge. According to themselves. You can figure out that progression is one member, and the others are those who follow along when a shit storm is to be carried out, either by liking each other's writings and/or they back each other up by contributing posts in the same style. As well as the posts I make, or others for that matter, if they are positive, they start coordinating their attack, as described above. They have not succeeded in making Bioporto go bankrupt, naturally, but they have succeeded in making so much noise that people have dumped their shares. But every time I and others come with negative news, there is silence from their side. I have long known that these attacks are coordinated, which I have claimed several times here on Nordnet social. Therefore, I have also actively looked for the smoking gun, and now I have found it and am sharing it here. Link to their closed club. https://www.nordnet.dk/forum/grupper/dk-progressionsklubben
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Why has Bioporto perhaps chosen to deliver a "decimated" quarterly report, where many of the usual details are omitted? And why hasn't 3D commented yet? Has 3D perhaps not noticed it?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    @Progression: Well, just that revenue increases while the loss decreases, and that is a good start to the year.
    1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    Revenue lands 6 % below the average quarterly sales in 2025. Has inflation been 4-5 % since 2025? Have sales on average fallen by 10 %? Is it the RSU sales that "drives" the business and not sales used in the healthcare sector? Is everything as it should be? The loss has become smaller vs Q1 25. Is there an explanation for the saving, has one sold fewer products at a higher price?
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Watch or rewatch Webcast Q 1 https://www.youtube.com/watch?v=FRc-y2wEHOM
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    It was a pleasure to hear the explanation that CB provided about KDIGO, because the analyses that I have arrived at, about KDIGO, and what it means for Bioporto, lean closely on what CB stated. The next thing I am excited about is whether I am also right that there will be a 1st degree recommendation for the critical areas, and a 2nd degree recommendation for other areas. (It is not unthinkable that there will be more recommendations than the two, so that it becomes as detailed as possible)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

DenmarkNasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
57--
2 865--
360--
5 425--
5 817--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q2 -tulosraportti
20.8.
Menneet tapahtumat
2026 Q1 -tulosraportti
21.5.
2025 Q4 -tulosraportti
26.3.
2025 Q3 -tulosraportti
19.11.2025
2025 Q2 -tulosraportti
15.8.2025
2025 Q1 -tulosraportti
8.5.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

2026 Q1 -tulosraportti
2 päivää sitten

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q2 -tulosraportti
20.8.
Menneet tapahtumat
2026 Q1 -tulosraportti
21.5.
2025 Q4 -tulosraportti
26.3.
2025 Q3 -tulosraportti
19.11.2025
2025 Q2 -tulosraportti
15.8.2025
2025 Q1 -tulosraportti
8.5.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 11 t sitten
    ·
    11 t sitten
    ·
    Just want to note that BP's increases historically have been driven by hysteria! These days/weeks/month(s) something "calmly" increasing is happening. And that, I think, is a sign of health. It doesn't jump by, for example, 75 øre. It seems to ground itself a bit à la two steps forward and one back. It looks calmer. It looks promising. Regards. Bagerbrød
    8 t sitten
    ·
    8 t sitten
    ·
    What could I possibly mean by "gently rising"?
    5 t sitten
    ·
    5 t sitten
    ·
    Thanks and likewise 😊🐾
  • 16 t sitten
    ·
    16 t sitten
    ·
    The price finally seems to be turning around, as there are green %-s for the last 6 months, but there is still room for improvement. 2.0 must be the next target this year.
    16 t sitten
    ·
    16 t sitten
    ·
    It depends on when KDIGO comes out with a 1st degree recommendation for the NGAL test. Those of us who have kept the stock in our portfolio, and have bought at the bottom, we can just lean back and watch all those who only buy when the announcement is made public. Bioporto has announced that they have already acquired 4 new hospitals in Q1. The reason why these hospitals have already integrated the NGAL test in Q1 and not in Q4, (see CBs explanation in Webcast Q 4 2025) is due to KDIGO's draft and the various announcements before the hearing concluded. We know that FDA will approve the adult test, it's just a question of when.
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    KDIGO guidelines likely the next catalyst - Q1 review https://access.dnbcarnegie.com/publication/ef21af0f-6d31-42be-0550-08deb7025c09
    5 t sitten
    ·
    5 t sitten
    ·
    Progression has formed a private club here on Nordnet, and there are 5 members. These are members who have all lost money on Bioporto, and they have made a pact to go together and commit a shit storm on Bioporto, on which they lost money, as revenge. According to themselves. You can figure out that progression is one member, and the others are those who follow along when a shit storm is to be carried out, either by liking each other's writings and/or they back each other up by contributing posts in the same style. As well as the posts I make, or others for that matter, if they are positive, they start coordinating their attack, as described above. They have not succeeded in making Bioporto go bankrupt, naturally, but they have succeeded in making so much noise that people have dumped their shares. But every time I and others come with negative news, there is silence from their side. I have long known that these attacks are coordinated, which I have claimed several times here on Nordnet social. Therefore, I have also actively looked for the smoking gun, and now I have found it and am sharing it here. Link to their closed club. https://www.nordnet.dk/forum/grupper/dk-progressionsklubben
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Why has Bioporto perhaps chosen to deliver a "decimated" quarterly report, where many of the usual details are omitted? And why hasn't 3D commented yet? Has 3D perhaps not noticed it?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    @Progression: Well, just that revenue increases while the loss decreases, and that is a good start to the year.
    1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    Revenue lands 6 % below the average quarterly sales in 2025. Has inflation been 4-5 % since 2025? Have sales on average fallen by 10 %? Is it the RSU sales that "drives" the business and not sales used in the healthcare sector? Is everything as it should be? The loss has become smaller vs Q1 25. Is there an explanation for the saving, has one sold fewer products at a higher price?
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Watch or rewatch Webcast Q 1 https://www.youtube.com/watch?v=FRc-y2wEHOM
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    It was a pleasure to hear the explanation that CB provided about KDIGO, because the analyses that I have arrived at, about KDIGO, and what it means for Bioporto, lean closely on what CB stated. The next thing I am excited about is whether I am also right that there will be a 1st degree recommendation for the critical areas, and a 2nd degree recommendation for other areas. (It is not unthinkable that there will be more recommendations than the two, so that it becomes as detailed as possible)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

DenmarkNasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
57--
2 865--
360--
5 425--
5 817--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt